Events & Awards

Events & Awards

AIM-HI Beacon Award for Women Leaders in Oncology

The AIM-HI Beacon Award for Women Leaders in Oncology recognizes outstanding women leaders in all sectors of the health and life sciences industry who have made a significant impact on advancing cancer treatment, detection, and diagnosis for patients worldwide through the development and commercialization of novel technologies, advocacy, and/or implementation of public policy.

2024 AIM-HI Beacon Award Selection Committee

  • Sujuan Ba, Ph.D., Co-Chair, CEO & Co-Founder, AIM-HI Accelerator Fund; President & CEO, National Foundation for Cancer Research
  • Webster Cavenee, Ph.D., Co-Chair, Distinguished Professor Emeritus, University of California San Diego
  • Bahija Jallal, Ph.D., CEO & Director of the Board, Immunocore
  • Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School
  • Patricia Obermaier, MBA, Chief Growth Officer, Global Health and Life Sciences, Microsoft
  • Libia Scheller, Ph.D., MBA, Global Head Oncology-Cooperative Groups & Strategic Alliances, Bayer Health Care Pharmaceuticals
  • Thea Tlsty, Ph.D., Professor, Department of Pathology and Director of the Center for Translational Research in the Molecular Genetics of Cancer, UCSF

Previous Recipients

NFCR Global Summit and Award Ceremonies
for Cancer Research and Entrepreneurship

Co-hosted by AIM-HI

We believe that when brilliant leaders are brought into the same space to focus on the same issues, progress happens. That’s why AIM-HI has curated an annual oncology conference in partnership with NFCR. The conference consists of three forums:

The 2024 NFCR Global Summit and Award Ceremonies will be held on Friday, October 18, 2024, in-person at the National Press Club in Washington, DC. Join this day to celebrate cancer research and entrepreneruship and engage with key opinion leaders in the field, including world-class scientists, biotech executives, entrepreneurs, Investors, cancer patients, and advocates.